Evidence map›Paper›PMID 23632086›Full record

ReviewMolecular pharmacology2013

The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization.

Graeme Milligan

Erratum issuedAbstract readReview
In one paragraph

Review in Molecular pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Allosteric Modulation of GPCRs of Class A by Cholesterol.International journal of molecular sciences · 2021
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Muscarinic receptor oligomerization.Neuropharmacology · 2018
    Review
  10. Hallucinogens and Serotonin 5-HTCurrent topics in behavioral neurosciences · 2018
    Review
  11. Breaking barriers to novel analgesic drug development.Nature reviews. Drug discovery · 2017
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

1 author.

Graeme MilliganMolecular Pharmacology Group, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom. Graeme.Milligan@glasgow.ac.uk

Funding

Medical Research Council G0900050
6 · The paper itself

Abstract

Over the past decade, ideas and experimental support for the hypothesis that G protein-coupled receptors may exist as dimeric or oligomeric complexes moved initially from heresy to orthodoxy, to the current situation in which the capacity of such receptors to interact is generally accepted but the prevalence, maintenance, and relevance of such interactions to both pharmacology and function remain unclear. A vast body of data obtained following transfection of cultured cells is still to be translated to native systems and, even where this has been attempted, results often remain controversial and contradictory. This review will consider approaches that are currently being applied and why these might be challenging to interpret, and will suggest means to overcome these limitations.

Indexed as

AnimalsHumansPrevalenceProtein MultimerizationReceptors, G-Protein-CoupledReceptors, G-Protein-Coupled

Identifiers

PMID23632086
PMCPMC3684826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.